Proposed PCB Congener Groupings for Epidemiological Studies
Health effects related to polychlorinated biphenyls (PCBs), which include 209 possible congeners exhibiting a variety of chlorine substitution patterns ( Fig. 1) , are the subject of numerous research investigations. Individual members of this family evoke diverse responses in experimental models and in humans. Certain PCB congeners mimic hormones and are neurotoxic (1) (2) (3) . Others produce a dioxinlike response, which has been attributed to steric homology with 2,3,7,8-tetrachlorodibenzodioxin (TCDD) (4, 5) . Epidemiologic studies have tended to report health effects expressed as the total of individual PCB congener levels or as the concentration relative to a commericial PCB mixture (e.g., Aroclor 1248, 1254, or 1260). However, as congener-specific analyses of serum, adipose tissue, and other media become routinely available, it is highly desirable to organize risk analysis along biologically plausible lines, thereby avoiding misclassification of exposure and strengthening the toxicologic associations.
One approach to interpreting PCBs in environmental materials is to group the dioxinlike PCB congeners together. With this method, a single index is computed as the sum of the congener concentrations weighted by their toxic equivalents relative to TCDD (4, 6) . However, analogous schema for estrogenic, neurotoxic, and cytochrome P450-inducing PCBs are not available at this time.
As a means of evaluating hormonal effects, Wolff and Toniolo (7) proposed a classification system based on structural, biological, and pharmacokinetic considerations. They assigned PCB congeners to three groups: estrogenic/neurotoxic, antiestrogenic (dioxinlike), and enzyme-inducing [phenobarbital (PB)-type cytochrome P450]. The desirability of developing such a system has been raised recently with respect to a number of ongoing research investigations that are attempting to relate exposure to organochlorines, including PCBs, with breast cancer risk (8). One of these studies, in which we are co-investiga- bFrom Vorhees (9). CBZ# is congener number as designated by Ballschmitter and Zell (10).
dRing 1 structure signifies biological activity for class 1 and 2. tors, is determining levels of PCBs in house dust as well as blood, providing an opportunity to assess exposure using internal and external measurements. As a starting point for discussion and initial classification, we suggest one possible set of PCB functional groupings (see Table 1 DDT and similar-acting compounds may be greatest during the height of rapid brain growth and during the rapid development of muscarinic acetylcholine receptors in the cerebral cortex (2) (3) (4) (5) . Although a direct comparison between the 10-day-old mice used in these studies and 10-day-old humans cannot be made, the sequence of events of brain development between humans and rodents is quite similar (6,7) That is, nerve production, myelin formation, receptor development, etc., are events that occur in the same order in rodents and humans (7). At day 10, mice are in their last stages of neuron production for the hippocampus and cerebellum (8). Antimitotic drugs are much more toxic if exposure occurs earlier in development when more neurons are being produced (9,10). However, the first 2 weeks of postnatal life in the rodent are a period of rapid development of synaptic connections, transmitter systems, and myelination. During this stage of brain development, exposure to teratogens leads to disruption of some or all of these events, resulting in permanent injury. For example, metals such as lead, cadmium, and organotin can injure the brain at this stage, as can hypothyroidism (11). The applicability of these teratology study results to the human situation will continue to become clearer as future findings delineate effects at developmental time points when mice are more sensitive and when the development of rodent and human neurosystems are similar.
It was with the consideration of this previously described experimental work that a breast milk study was initiated in the state of Washington to access a population of concern consisting primarily of lowincome Hispanics. We conducted this study to 1) determine actual levels of DDT and DDE in breast milk of mothers residing in the Yakima River basin; 2) assess the relative impact of fish consumption on the total DDT/DDE body burden; and 3) determine if total DDT and DDE levels received by breast-feeding infants were elevated to potentially deleterious levels. Fish collected from the Yakima River between 1989 and 1991 had DDT and DDE levels among the highest recorded in the United States (12). We were concerned that mothers who frequently consumed Yakima River bottom-feeding fish could have breast milk DDT and DDE concentrations sufficiently high to expose their infants to potentially deleterious levels of these compounds. Among the 36 individuals sampled (12 individuals for each of three cohorts: fish consumers, Mexico-born nonconsumers, and U.S.-born nonconsumers); results indicated that fish consumption did not significantly increase DDT/ DDE breast milk concentrations. However, as has been reported elsewhere, subjects born in Mexico had significantly elevated levels of DDT and DDE (p < 0.01) in breast milk compared to levels found in subjects born in the United States (1, 13, 14) .
For each cohort sampled, an infant DDT intake level was determined using the breast milk value that included twothirds of that particular cohort. For a 5-kg infant consuming 1 kg breast milk daily, infant DDT intake levels for the cohorts were in the range of 0.7-3.5 x 10-3 mg/kg/day. These results do not include two outliers from the Mexico-born nonconsumer cohort who had DDT/DDE levels greater than two standard deviations from the mean. Our infant exposure values derived from the cohort data (excluding outliers) were more than two orders of magnitude below the administered dose used by Eriksson et al. (2) (3) (4) . The two women (considered outliers) had DDT breast milk levels that correspond to the elevated levels observed in women living in Mexico. These DDT breast milk levels would expose breast-feeding infants each day to levels that are less than two orders of magnitude from the one-time administered dose given to neonatal mice.
Although DDT may contribute to an increase in breast cancer, exposure to DDT may also produce neurological and developmental endpoints of significance that require consideration. The study conducted in Washington State and data on breast milk DDT levels obtained from women in Mexico indicate that infants may be exposed to potentially deleterious levels of these compounds through breast milk. With DDT in our environment, various populations can still be exposed to sufficiently elevated DDT levels in the United States that warrant concern. Also, due to the influx of Mexico-born women into the United States, their U.S.-born infants may be a population of concern. Future research in this area should consider the feasibility of detecting these neurological and developmental outcomes in individuals that have been previously exposed as infants, and not just for those living in areas where DDT is still in use but also in countries or areas where use has been banned or severly restricted.
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